- Aug 10, 2021 Foghorn Therapeutics Provides Second Quarter 2021 Corporate Update
- Aug 03, 2021 Foghorn Therapeutics to Participate at the 2021 Wedbush PacGrow Healthcare Virtual Conference
- Jul 09, 2021 Foghorn Therapeutics to Participate at the William Blair Biotech Focus Conference 2021
- Jun 08, 2021 Foghorn Therapeutics to Host Research & Development Day Webinar on June 15th
- May 26, 2021 Foghorn Therapeutics to Present in Two Upcoming Investor Conferences
- May 17, 2021 Foghorn Therapeutics Announces Dosing of First Patient in First-in-Human Clinical Program of FHD-286
- May 11, 2021 Foghorn Therapeutics Provides Corporate Update
- Apr 28, 2021 Foghorn Therapeutics Appoints Ian Smith to its Board of Directors
- Mar 18, 2021 Foghorn Therapeutics Provides Corporate Update
- Mar 11, 2021 UPDATE: Foghorn Therapeutics to Present Poster and Chair a Panel at the AACR Annual Meeting 2021
Displaying 101 - 110 of 119